Terapias Avanzadas para Tumores Sólidos Pediátricos
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro Nacional de Investigaciones Cardiovasculares Carlos III (6)
2023
2018
-
Intratumoral immunotherapy with XCL1 and sFlt3L encoded in recombinant semliki forest virus–derived vectors fosters dendritic cell–mediated t-cell cross-priming
Cancer Research, Vol. 78, Núm. 23, pp. 6643-6654
-
Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) Costimulation
Cancer Immunology Research, Vol. 6, Núm. 7, pp. 798-811
2017
-
CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes
OncoImmunology, Vol. 6, Núm. 4
2016
-
Cancer immunotherapy with immunomodulatory anti-CD137 and anti–PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells
Cancer Discovery, Vol. 6, Núm. 1, pp. 71-79
2011
-
Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes
Cancer Research, Vol. 71, Núm. 3, pp. 801-811